Theracurmin®  	Theracurmin®  	 NNP	B-NP
efficiently  	efficiently  	 RB	O
inhibits  	inhibits  	 VB	O
the  	the  	 DT	O
growth  	growth  	 NN	B-NP
of  	of  	 IN	O
human  	human  	 JJ	O
prostate  	prostate  	 NN	B-NP
and  	and  	 CC	O
bladder  	bladder  	 JJ	O
cancer  	cancer  	 NN	O
cells  	cells  	 NNS	O
via  	via  	 IN	O
induction  	induction  	 NN	B-NP
of  	of  	 IN	I-NP
apoptotic  	apoptotic  	 JJ	I-NP
cell  	cell  	 NN	I-NP
death  	death  	 NN	I-NP
and  	and  	 CC	O
cell  	cell  	 NN	O
cycle  	cycle  	 NN	O
arrest  	arrest  	 NN	O
In  	In  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
aimed  	aimed  	 VBD	O
to  	to  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
anticancer  	anticancer  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
of  	of  	 IN	I-NP
Theracurmin® 	Theracurmin® 	 NNP	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
novel  	novel  	 NN	O
form  	form  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
yellow  	yellow  	 JJ	O
curry  	curry  	 JJ	B-NP
pigment  	pigment  	 NN	I-NP
curcumin 	curcumin 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 RB	O
explore  	explore  	 VB	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
potential  	potential  	 JJ	I-NP
anticancer  	anticancer  	 JJ	I-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
Theracurmin®  	Theracurmin®  	 CD	I-NP
on  	on  	 IN	O
human  	human  	 JJ	O
prostate  	prostate  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
and  	and  	 CC	O
bladder  	bladder  	 JJ	O
cancer  	cancer  	 NN	O
cells  	cells  	 NNS	O
in vitro 	in vitro 	 VBP	O
.  	.  	 .	O
The  	The  	 DT	O
proliferation  	proliferation  	 NN	B-NP
of  	of  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
cells  	cells  	 NNS	I-NP
was  	was  	 VBD	O
examined  	examined  	 VBN	O
by  	by  	 IN	O
using  	using  	 VBG	O
the  	the  	 DT	O
Cell  	Cell  	 NNP	O
Counting  	Counting  	 NNP	B-NP
Kit-8 	Kit-8 	 NNP	I-NP
.  	.  	 .	O
The  	The  	 DT	O
clonogenic  	clonogenic  	 JJ	B-NP
growth  	growth  	 NN	I-NP
potential  	potential  	 NN	I-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
clonogenic  	clonogenic  	 JJ	B-NP
assay 	assay 	 NN	I-NP
.  	.  	 .	O
Cell  	Cell  	 NN	O
cycle  	cycle  	 NN	O
distribution  	distribution  	 NN	O
was  	was  	 VBD	O
evaluated  	evaluated  	 VBN	O
by  	by  	 IN	O
flow  	flow  	 NN	O
cytometry  	cytometry  	 VBZ	O
using  	using  	 VBG	O
propidium  	propidium  	 JJ	B-NP
iodide  	iodide  	 JJ	I-NP
staining 	staining 	 NN	I-NP
.  	.  	 .	O
Western  	Western  	 JJ	O
blot  	blot  	 JJ	O
analysis  	analysis  	 NN	O
was  	was  	 VBD	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
explore  	explore  	 VB	O
the  	the  	 DT	O
expression  	expression  	 NN	B-NP
patterns  	patterns  	 NNS	I-NP
of  	of  	 IN	O
molecules  	molecules  	 NNS	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
apoptotic  	apoptotic  	 JJ	B-NP
cell  	cell  	 NN	I-NP
death  	death  	 NN	I-NP
and  	and  	 CC	O
cell  	cell  	 NN	O
cycle  	cycle  	 NN	O
checkpoint 	checkpoint 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
noted  	noted  	 VBD	O
that  	that  	 IN	O
Theracurmin®  	Theracurmin®  	 NNP	B-NP
and  	and  	 CC	O
curcumin  	curcumin  	 JJ	B-NP
exhibited  	exhibited  	 JJ	I-NP
similar  	similar  	 JJ	O
anticancer  	anticancer  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
in  	in  	 IN	O
both  	both  	 DT	O
androgen-dependent  	androgen-dependent  	 JJ	B-NP
and  	and  	 CC	O
-independent  	-independent  	 JJ	O
human  	human  	 JJ	O
prostate  	prostate  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
cells  	cells  	 NNS	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
dose-  	dose-  	 JJ	O
and  	and  	 CC	O
time-dependent  	time-dependent  	 JJ	B-NP
manner 	manner 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
agents  	agents  	 NNS	O
reduced  	reduced  	 VBN	O
cell  	cell  	 NN	O
viability  	viability  	 NN	O
and  	and  	 CC	O
clonogenic  	clonogenic  	 JJ	B-NP
growth  	growth  	 NN	I-NP
potential  	potential  	 NN	I-NP
by  	by  	 IN	O
inducing  	inducing  	 VBG	B-NP
apoptosis  	apoptosis  	 NNS	I-NP
and  	and  	 CC	O
cell  	cell  	 NN	O
cycle  	cycle  	 NN	O
disturbance  	disturbance  	 NN	O
in  	in  	 IN	O
human  	human  	 JJ	O
prostate  	prostate  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Theracurmin®  	Theracurmin®  	 NNP	B-NP
and  	and  	 CC	O
curcumin  	curcumin  	 VBP	O
also  	also  	 RB	O
exerted  	exerted  	 VBN	O
marked  	marked  	 VBN	O
anticancer  	anticancer  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
on  	on  	 IN	O
human  	human  	 JJ	O
bladder  	bladder  	 NN	O
cancer  	cancer  	 NN	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
even  	even  	 RB	O
in  	in  	 IN	O
cisplatin-resistant  	cisplatin-resistant  	 JJ	O
T24R2  	T24R2  	 CD	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
in  	in  	 IN	O
a  	a  	 DT	O
dose-  	dose-  	 JJ	O
and  	and  	 CC	O
time-dependent  	time-dependent  	 JJ	B-NP
manner 	manner 	 NN	I-NP
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
Theracurmin®  	Theracurmin®  	 NNP	B-NP
and  	and  	 CC	O
curcumin  	curcumin  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
decreased  	decreased  	 VBD	O
cell  	cell  	 NN	O
viability  	viability  	 NN	O
and  	and  	 CC	O
clonogenicity  	clonogenicity  	 NN	B-NP
via  	via  	 IN	O
induction  	induction  	 NN	B-NP
of  	of  	 IN	I-NP
apoptotic  	apoptotic  	 JJ	I-NP
cell  	cell  	 NN	I-NP
death  	death  	 NN	I-NP
and  	and  	 CC	O
cell  	cell  	 NN	B-NP
cycle  	cycle  	 NN	I-NP
dysregulation  	dysregulation  	 NN	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
bladder  	bladder  	 NN	O
cancer  	cancer  	 NN	O
cells 	cells 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
our  	our  	 PRP$	O
study  	study  	 NN	O
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
Theracurmin®  	Theracurmin®  	 NNP	B-NP
has  	has  	 VBZ	O
potential  	potential  	 JJ	O
as  	as  	 IN	O
an  	an  	 DT	O
anticancer  	anticancer  	 JJ	B-NP
agent  	agent  	 NN	I-NP
in  	in  	 IN	O
complementary  	complementary  	 JJ	O
and  	and  	 CC	O
alternative  	alternative  	 JJ	O
medicine  	medicine  	 NN	O
for  	for  	 IN	O
these  	these  	 DT	O
urological  	urological  	 JJ	B-NP
cancers 	cancers 	 NNS	I-NP
.  	.  	 .	O
